Patent Issued for Enhancement of tumor response to chemotherapy by activation of the asmase/ceramide pathway through timed administration of a short-acting anti-angiogenic agent (USPTO 11285137)

2022 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Angiogenesis Weekly -- A patent by the inventors Fuks, Zvi (New York, NY, US), Haimovitz-Friedman, Adriana (New York, [...]